- Home
- PENG vs PLRX Comparison
PENG vs PLRX Comparison
Compare PENG & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PENG
- PLRX
- Stock Information
- Founded
- PENG 1988
- PLRX 2015
- Country
- PENG Cayman Islands
- PLRX United States
- Employees
- PENG N/A
- PLRX N/A
- Industry
- PENG Semiconductors
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- PENG Technology
- PLRX Health Care
- Exchange
- PENG Nasdaq
- PLRX Nasdaq
- Market Cap
- PENG 830.2M
- PLRX 680.3M
- IPO Year
- PENG 2017
- PLRX 2020
- Fundamental
- Price
- PENG $20.11
- PLRX $11.37
- Analyst Decision
- PENG Strong Buy
- PLRX Strong Buy
- Analyst Count
- PENG 7
- PLRX 7
- Target Price
- PENG $25.43
- PLRX $40.50
- AVG Volume (30 Days)
- PENG 1.0M
- PLRX 485.5K
- Earning Date
- PENG 01-08-2025
- PLRX 02-26-2025
- Dividend Yield
- PENG N/A
- PLRX N/A
- EPS Growth
- PENG N/A
- PLRX N/A
- EPS
- PENG N/A
- PLRX N/A
- Revenue
- PENG $1,237,651,000.00
- PLRX N/A
- Revenue This Year
- PENG $18.38
- PLRX N/A
- Revenue Next Year
- PENG $10.03
- PLRX N/A
- P/E Ratio
- PENG N/A
- PLRX N/A
- Revenue Growth
- PENG N/A
- PLRX N/A
- 52 Week Low
- PENG $14.87
- PLRX $10.22
- 52 Week High
- PENG $29.81
- PLRX $18.00
- Technical
- Relative Strength Index (RSI)
- PENG N/A
- PLRX 44.60
- Support Level
- PENG N/A
- PLRX $10.35
- Resistance Level
- PENG N/A
- PLRX $11.07
- Average True Range (ATR)
- PENG 0.00
- PLRX 0.61
- MACD
- PENG 0.00
- PLRX 0.06
- Stochastic Oscillator
- PENG 0.00
- PLRX 43.50
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.